AlensiaXR key facts
as of Oct 2026- Developer of a learning platform intended to transform the way students learn human anatomy.
- AlensiaXR is valued at approximately $20.0M as of Oct 2026 (last reported valuation).
- It has raised $5.3M; the latest was Early Stage VC ($2.1M) in Jan 2026.
- Notable investors include Jumpstart Ventures, JobsOhio Ventures, University Hospitals Ventures, Case Western Reserve University, Sopris Venture Capital.
- Status: Privately Held (backing).
AlensiaXR's last reported valuation, Jan 2026. Nothing priced has surfaced since.
- ·Watch AlensiaXR: the Monday email on marks, rounds and moves
AlensiaXR funding rounds
No funding rounds for AlensiaXR are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
AlensiaXR valuation
AlensiaXR's last reported valuation was $20 million in Jan 2026. No priced round, secondary trade or fund mark has surfaced since.
AlensiaXR investors
5 investors are on record for AlensiaXR, including Jumpstart Ventures, JobsOhio Ventures, University Hospitals Ventures and Case Western Reserve University.
About AlensiaXR
Developer of a learning platform intended to transform the way students learn human anatomy. The company's platform uses advanced mixed-reality technology to illuminate the human body in three dimensions, which helps students to learn fast, retain vital information and transcend the classroom, enabling students to easily learn anatomical content and universities can reduce the expensive, time-consuming tasks of obtaining and maintaining cadavers.
- Sector
- Information Technology
- HQ
- Aurora, OH, United States
- Founded
- 2024
- Employees
- 20
- Website
- alensiaxr.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.